This application note explores optimized culturing conditions for precision-cut slices (PCS) of non-small cell lung carcinoma ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Patient-derived organoids (PDOs) are revolutionizing cancer research, enhancing drug testing and personalized treatment ...

Filippo Veglia, Ph.D., of Wistar’s Genome Regulation and Cell Signaling Program, discusses the most lethal form of brain ...

Israeli researchers and their colleagues from the United States developed an antibody-based treatment that empowers the ...

The immune microenvironment around a pancreatic tumor has suppressed immune activity, allowing the tumor to evade attacks by ...

They also wanted to study the role of Pin1 in the crosstalk between pancreatic cancer cells and the tumor microenvironment — ...

A team of scientists has used a novel approach to identify protein degraders that target Pin1, a protein involved in pancreatic cancer development.

Biopsy-only patients demonstrated longer progression-free ... most common malignant brain tumor, experienced tumor control after complete in-situ vaccination and anti-PD-1 immunotherapy, which ...